Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A
neurokinin receptor antagonist undergoing research for the treatment ofchemotherapy -inducednausea andvomiting .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word casopitant.
Examples
-
Nano drug ALX-0081 from Ablynx to open up blocked blood vessels coming Non opium pain drug tezampanel can treat acute migraine, says Raptor GlaxoSmithKline withdraws Zunrisa (casopitant) filings on safety fears Drug to improve cognition in Alzheimer's patients Lu AE58054 in human studies: Lundbeck US FDA seeks more data on Sanofi-Aventis sleep drug eplivanserin (Ciltyril)
DWS Full News Feed 2010
-
Merck GlaxoSmithKline withdraws Zunrisa (casopitant) filings on safety fears Novartis 'indacaterol (QAB149) to treat COPD needs more data on dosing: US FDA
DWS Pill Scribe 2009
-
The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the
CancerConsultants 2009
-
The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the
CancerConsultants 2009
-
The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the
CancerConsultants 2009
-
The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the
CancerConsultants 2009
-
The addition of Rezonic ™ (casopitant) to Zofran® (ondansetron) and dexamethasone significantly reduces chemotherapy-induced nausea and vomiting compared with Zofran and dexamethasone alone, according to the results of a study published in the
CancerConsultants 2009
-
ZUNRISA ™, the proposed trade name for casopitant, is a trademark of the GlaxoSmithKline group of companies.
-
(casopitant); the oxidative stress inducer, elesclomol, for metastatic melanoma and the antigen-specific cancer immunotherapeutic, MAGE-A3 ASCI for non-small cell lung cancer and metastatic melanoma.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.